Provectus Biopharmaceuticals, Inc. (PVCT) - Stock Prices, Stock Peers & Analysis

Home
PVCT

Company Name	Provectus Biopharmaceuticals, Inc.
Symbol	PVCT
Currency	USD
Price	0.149
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	62,550,728
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.052 - 0.19
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Eric A. Wachter
Website	https://www.provectusbio.com

An error occurred while fetching data.

About Provectus Biopharmaceuticals, Inc.

Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes. It develops PV-10, an investigational autolytic cancer immunotherapy for adult solid tumor cancers, such as melanoma and gastrointestinal tumors, including hepatocellular carcinoma; colorectal cancer metastatic to the liver; neuroendocrine tumors metastatic to the liver;